GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Enzymatica AB (XSAT:ENZY) » Definitions » Price-to-Free-Cash-Flow

Enzymatica AB (XSAT:ENZY) Price-to-Free-Cash-Flow : N/A (As of May. 18, 2024)


View and export this data going back to . Start your Free Trial

What is Enzymatica AB Price-to-Free-Cash-Flow?

As of today (2024-05-18), Enzymatica AB's share price is kr9.00. Enzymatica AB's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was kr-1.44. Hence, Enzymatica AB's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Enzymatica AB's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 13 years, Enzymatica AB's highest Price-to-Free-Cash-Flow Ratio was 100.53. The lowest was 0.00. And the median was 97.46.

XSAT:ENZY's Price-to-Free-Cash-Flow is not ranked *
in the Drug Manufacturers industry.
Industry Median: 23.5
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Enzymatica AB's Free Cash Flow per Share for the three months ended in Mar. 2024 was kr-0.30. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was kr-1.44.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -32.30% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -4.20% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 17.90% per year.

During the past 13 years, Enzymatica AB's highest 3-Year average Free Cash Flow per Share Growth Rate was 46.60% per year. The lowest was -418.90% per year. And the median was 2.40% per year.


Enzymatica AB Price-to-Free-Cash-Flow Historical Data

The historical data trend for Enzymatica AB's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzymatica AB Price-to-Free-Cash-Flow Chart

Enzymatica AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Enzymatica AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Enzymatica AB's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Enzymatica AB's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enzymatica AB's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Enzymatica AB's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Enzymatica AB's Price-to-Free-Cash-Flow falls into.



Enzymatica AB Price-to-Free-Cash-Flow Calculation

Enzymatica AB's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=9.00/-1.443
=N/A

Enzymatica AB's Share Price of today is kr9.00.
Enzymatica AB's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-1.44.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Enzymatica AB  (XSAT:ENZY) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Enzymatica AB Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Enzymatica AB's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Enzymatica AB (XSAT:ENZY) Business Description

Traded in Other Exchanges
Address
Scheelevagen 19, Delta 5, Ideon Science Park, Lund, SWE, SE-223 70
Enzymatica AB is a life science company that develops and sells medical devices against infectious diseases, based on a barrier technology, which includes marine enzymes. Its product ColdZyme Mouth Spray prevents cold and reduces disease period.

Enzymatica AB (XSAT:ENZY) Headlines

From GuruFocus

Tiger Management Founder Julian Robertson Ups Stake in Enzymotec

By Kyle Ferguson Kyle Ferguson 12-07-2015

Julian Robertson Cuts Half of Stake in Paulson-Backed Company

By Holly LaFon Holly LaFon 07-01-2016

Julian Robertson Adds to Multiple Positions in 3rd quarter

By Tiziano Frateschi Tiziano Frateschi 12-20-2016